Navigation Links
VisionGate Reports Advances In Its Cell-CT(TM) Automated 3D Cell Analysis Platform At ASC 2012 Scientific Meeting
Date:11/6/2012

PHOENIX, Nov. 6, 2012 /PRNewswire/ -- VisionGate, Inc., today reported that it presented new data confirming that its breakthrough Cell-CT™ platform for the automated analysis of three dimensional (3D) images of cells can identify disease-associated features that are not visible using 2D cytology.  The data were presented this week by VisionGate founder and CEO Alan Nelson, PhD, at the 60th Annual Scientific Meeting of the American Society of Cytopathology.

The Cell-CT produces 3D volumetric computed reconstructions of individual cells in very high resolution, using advanced digital microscopy technology.  The high resolution afforded by the Cell-CT's 3D imaging is critical for automated machine recognition of cell abnormalities.  In his presentation, Dr. Nelson showed that certain disease-associated cell features that are not visible in 2D imaging emerge in the 3D images generated by the Cell-CT.  Unlike 2D imaging, the Cell-CT's 3D images enable comprehensive analysis of each individual cell, illuminating the morphological features and providing the analytical information needed for accurate disease detection.

"The Cell-CT platform has the potential to enable the non-invasive early detection of serious diseases such as lung cancer, while transforming the role of the cytologist," commented Dr. Nelson. "The Cell-CT system is now fully automated, and we are on track to achieve imaging speeds of one cell per second, which makes high throughput automated screening feasible for cancer and other conditions."

In clinical applications, the Cell-CT can generate high-resolution 3D biosignatures from cells contained in patient samples such as sputum or blood, which may contain cancer cells that can be detected early in the disease process.  The biosignatures discovered in the 3D high resolution images may allow the Cell-CT to identify abnormal cells before symptoms appear.  In screening applications, advantages over
'/>"/>

SOURCE VisionGate, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. VisionGate Uses $2.6 Million NIH Grant to Achieve Full Automation of Cell-CT™ 3D Imaging System for Early Diagnosis of Cancer
2. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
3. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
4. Interleukin Genetics Reports Third Quarter 2011 Financial Results
5. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
6. Nile Therapeutics Reports 2011 Third Quarter Financial Results
7. Pharmasset Reports Fiscal Year End 2011 Financial Results
8. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
9. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
10. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
11. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Nasseo, Inc. today announces that it has been ... of applicants by the Arizona Commerce Authority (ACA) ... The Arizona Innovation Challenge (AIC) awards the most money ... a financial award to what it deems to be ... the art dental and orthopedic implant surface modification technology ...
(Date:6/18/2013)... June 18, 2013 ... research firm, announces the initiation of full ... biopharmaceutical company developing and marketing products for ...      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... examining the investment merits of BioAlliance Pharma, ...
(Date:6/18/2013)... MINNEAPOLIS , June 18, 2013  Techne ... today that it has agreed to acquire 100% ... subsidiary Bionostics, Inc. (Bionostics).  Bionostics is a global ... control solutions that verify the proper operation of ... utilized in point of care blood glucose and ...
(Date:6/18/2013)... THE WOODLANDS, Texas , June 18, 2013 ... LXRX ), a biopharmaceutical company focused on ... that John Northcott has joined the ... strategy, and operations. Mr. Northcott brings extensive commercial ... on-market commercialization across a variety of therapeutic areas. ...
Breaking Biology Technology:Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3
... subsidiary obtains $74 million term loanST. LOUIS, May 6 2009 First Quarter ... Net sales decreased to $339 million from $517 million in the first ... EBITDA decreased to $56 million from $95 million in the first quarter of 2008 ... report improved Adjusted EBITDA margins , ...
... First Quarter Financial Results Conference Call and Webcast -CHICAGO, ... today that its common stock is eligible for quotation ... the trading symbol "ADLS." The Company also announced today ... discussing the Company,s 2009 first quarter results on Tuesday, ...
... Technology experts from over 20 countries are in ... environment, topics of global importance and immediacy. The ... forum to discuss initiatives in micromachining and nano ... economic and social outcomes. , The Summit promotes ...
Cached Biology Technology:Solutia Reports First Quarter 2009 Results 2Solutia Reports First Quarter 2009 Results 3Solutia Reports First Quarter 2009 Results 4Solutia Reports First Quarter 2009 Results 5Solutia Reports First Quarter 2009 Results 6Solutia Reports First Quarter 2009 Results 7Solutia Reports First Quarter 2009 Results 8Solutia Reports First Quarter 2009 Results 9Solutia Reports First Quarter 2009 Results 10Solutia Reports First Quarter 2009 Results 11Solutia Reports First Quarter 2009 Results 12Solutia Reports First Quarter 2009 Results 13Solutia Reports First Quarter 2009 Results 14Solutia Reports First Quarter 2009 Results 15Solutia Reports First Quarter 2009 Results 16Solutia Reports First Quarter 2009 Results 17Solutia Reports First Quarter 2009 Results 18Solutia Reports First Quarter 2009 Results 19Solutia Reports First Quarter 2009 Results 20Solutia Reports First Quarter 2009 Results 21Advanced Life Sciences Common Stock Begins Trading on OTC Bulletin Board 2World Micromachine Summit highlights technologies impacting energy and the environment 2
(Date:6/17/2013)... fungi, bacteria, and algae, is a common component of ... in the medical field it,s approved by the ... and used during surgery as a substance that opens ... drugs. , Now Profs. Ehud Gazit and Daniel Segal ... Biotechnology and the Sagol School of Neuroscience, along with ...
(Date:6/17/2013)... 2013) The AGA Research Foundation and Horizon Pharma ... of gastroenterology with the 2013 AGA-Horizon Pharma Fellow Abstract ... , "In its third year, this competition continues to ... on promising careers in basic and clinical research," said ... Research Foundation. "We are extremely proud of all that ...
(Date:6/17/2013)... CORVALLIS, Ore. Amphibian populations are declining worldwide and ... be spread by bullfrogs, but a two-year study shows ... suggestions that bullfrogs are a tolerant carrier host that ... frogs from eggs in controlled experimental conditions, they found ... dendrobatidis , also called Bd or a chytrid fungus, ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2Horizon Pharma Abstract Prizes recognize promising fellows and students 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... Duchenne muscular dystrophy (DMD) tend to manage well through ... early adulthood, or why elderly people who lose muscle ... to regain. Now, researchers at the National Institute of ... the National Institutes of Health, are beginning to find ...
... Palo Alto, CABrazilians are world leaders in using biofuels ... consumption comes from sugarcane, which significantly reduces carbon dioxide ... Now scientists from the Carnegie Institution,s Department of Global ... Expansion of the crop in areas previously occupied by ...
... Michael Croft, Ph.D., a researcher at the La ... molecule,s previously unknown role as a major trigger for ... a promising therapeutic target for chronic asthma, chronic obstructive ... A scientific paper on Dr. Croft,s finding was published ...
Cached Biology News:NIH scientists identify gene that could hold the key to muscle repair 2Sugarcane cools climate 2La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders 2La Jolla Institute identifies new therapeutic target for asthma, COPD and other lung disorders 3
... TempliPhi 500 Amplification Kit, 500 reactions. ... sequencing in 4-6 h.Generate microgram quantities ... of starting material.Use amplified DNA directly ... from bacterial or M13 liquid cultures, ...
For quantitative determination of Aldolase in Serum (an indicator of muscle damage). Ready-to-use liquid stable reagent. Formulated to eliminate interference from pyruvates. Application sheets are ...
Autoclavable, variable volumefitted w./ an anti-drip safety valve; borosilicate glass barrelprotected with transparentpolypropylene sleeve; spring-lock cursor design ensuresfine adjustment for exact ...
Antibodies were affinity purified using epitopes specific to RFC1 immobilized on solid support....
Biology Products: